Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer

DOI10.1111/J.1541-0420.2011.01572.XzbMATH Open1274.62922OpenAlexW2049655669WikidataQ30502590 ScholiaQ30502590MaRDI QIDQ2893403FDOQ2893403

Authors: Yufan Zhao, Donglin Zeng, Mark A. Socinski, Michael R. Kosorok 

Publication date: 20 June 2012

Published in: Biometrics (Search for Journal in Brave)

Full work available at URL: http://europepmc.org/articles/pmc3138840

Recommendations

• Q-learning with censored data
• \(Q\)- and \(A\)-learning methods for estimating optimal dynamic treatment regimes
• Penalized Q-learning for dynamic treatment regimens
• New statistical learning methods for estimating optimal dynamic treatment regimes
• Tree-based reinforcement learning for estimating optimal dynamic treatment regimes

zbMATH Keywords

\(Q\)-learningpersonalized medicinereinforcement learningsupport vector regressionadaptive designdynamic treatment regimeindividualized therapymultistage decision problemsnonsmall cell lung cancer

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)

Cites Work

• Title not available (Why is that?)
• A generalization error for Q-learning
• Optimal Dynamic Treatment Regimes
• Optimal Structural Nested Models for Optimal Sequential Decisions
• Extremely randomized trees
• Kernel-based reinforcement learning
• Title not available (Why is that?)

Cited In (30)

• Flexible inference of optimal individualized treatment strategy in covariate adjusted randomization with multiple covariates
• Recursively Imputed Survival Trees
• iFusion: Individualized Fusion Learning
• Stochastic Tree Search for Estimating Optimal Dynamic Treatment Regimes
• Reinforcement learning-based control of drug dosing for cancer chemotherapy treatment
• Title not available (Why is that?)
• Estimating Mean Survival Time: When is it Possible?
• Estimating optimal individualized treatment rules with multistate processes
• High-Dimensional Precision Medicine From Patient-Derived Xenografts
• Using decision lists to construct interpretable and parsimonious treatment regimes
• On estimating optimal regime for treatment initiation time based on restricted mean residual lifetime
• Q-learning with censored data
• Learning Non-monotone Optimal Individualized Treatment Regimes
• Multicategory Angle-Based Learning for Estimating Optimal Dynamic Treatment Regimes With Censored Data
• Doubly-robust dynamic treatment regimen estimation via weighted least squares
• Estimating treatment effect heterogeneity in randomized program evaluation
• Deep reinforcement learning for personalized treatment recommendation
• Q-learning for estimating optimal dynamic treatment rules from observational data
• Robust Inference of Conditional Average Treatment Effects Using Dimension Reduction
• Robust Q-Learning
• Functional Feature Construction for Individualized Treatment Regimes
• Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules
• Interpretable Dynamic Treatment Regimes
• Deep spatial Q-learning for infectious disease control
• Estimating Individualized Treatment Rules Using Outcome Weighted Learning
• Sequential Advantage Selection for Optimal Treatment Regimes
• On sparse representation for optimal individualized treatment selection with penalized outcome weighted learning
• Optimal adaptive control of drug dosing using integral reinforcement learning
• Personalized dynamic treatment regimes in continuous time: a Bayesian approach for optimizing clinical decisions with timing
• Optimal Treatment Regimes: A Review and Empirical Comparison

This page was built for publication: Reinforcement learning strategies for clinical trials in nonsmall cell lung cancer

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2893403)